「Canaud技术」用于医师改良胸主动脉腔内移植物治疗主动脉弓疾病的解剖学可行性
本研究分析2009年1月至2023年7月本机构164例主动脉弓病变患者的CT血管造影,评估「Canaud技术」医师改良胸主动脉腔内移植物(C-PMEG)的解剖学可行性。双开窗C-PMEG适合20例(12.2%),单开窗适合34例(20.7%),合计32.9%;联合 adjunctive 措施后可行性达42.1%,加用髂动脉 conduit 后达43.9%。主要排除原因为升主动脉直径过大(78例,47.6%)。
要点
- C-PMEG解剖学可行率为32.9%至43.9%。
- 双开窗C-PMEG适合20例(12.2%),单开窗适合34例(20.7%)。
- 主要排除原因为升主动脉直径过大(78例,47.6%)。
核心结论
- C-PMEG在32.9%至43.9%的主动脉弓动脉瘤、夹层和穿透性主动脉溃疡患者中理论上是可行的。
- 主要排除原因为升主动脉尺寸。
- C-PMEG技术是主动脉弓病变腔内治疗的可选方案。
- 具有类似特性的现货器械也可用于急诊,避免医师改良的限制(如台面操作时间、无菌性、超说明书使用)。
研究设计与样本
- 回顾性分析2009年1月至2023年7月本机构连续209例候选开放、杂交或腔内主动脉弓修复患者的CT血管造影,其中164例有可分析的术前CTA。
- 126例为男性(76.8%),平均年龄67±10.8岁。
- 94例(57.3%)为动脉粥样硬化性动脉瘤,48例(29.3%)为夹层后动脉瘤,22例(13.4%)为穿透性主动脉溃疡(PAU)。
- C-PMEG可行性评估遵循先前详细描述的解剖学标准。
主要发现
- 20例(12.2%)适合双开窗C-PMEG,34例(20.7%)适合单开窗C-PMEG,合计占整个队列的32.9%。
- 联合主动脉上干(SAT)搭桥或使用覆膜支架于无名动脉(IA)或左颈总动脉(LCCA)作为辅助措施,可将C-PMEG可行性扩展至69例(42.1%)。
- 对3例(1.8%)髂股入路不佳的患者使用髂动脉移植物conduit,可将C-PMEG适用性提高至72例(43.9%)。
- 主要排除原因为升主动脉直径过大,共78例(47.6%)。
关键数值与推荐
- 双开窗C-PMEG适合20例(12.2%)。
- 单开窗C-PMEG适合34例(20.7%)。
- 联合SAT搭桥或IA/LCCA覆膜支架后可行性为69例(42.1%)。
- 加用髂动脉conduit后可行性为72例(43.9%)。
- 升主动脉直径过大排除78例(47.6%)。
临床怎么用
- C-PMEG技术是主动脉弓病变腔内治疗的可选方案。
- 具有类似特性的现货器械也可用于急诊,避免医师改良的限制(如台面操作时间、无菌性、超说明书使用)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Thoracic endovascular aortic repair (TEVAR), originally conceived for deployment distal to the left subclavian artery (LSA), has been recently extended to more proximal landing zones. Among total endovascular solutions, the "Canaud technique" for Physician-Modified Thoracic Endovascular Grafts (C-PMEGs) has gained acceptance with good early results. The aim of this study is to report the proportion of patients with zone 0, 1, and 2 aortic arch lesions that could theoretically be treated with a C-PMEG. MATERIALS AND METHODS: Computed tomography angiography (CTA) of all consecutive patient candidates to open, hybrid, or endovascular arch repair from January 2009 to July 2023 at our Institution were analyzed. The assessment of feasibility of C-PEMG was conducted following previously extensively described anatomical criteria. RESULTS: During the study period, 209 consecutive patients were candidates for an open, hybrid, or endovascular aortic arch repair. Of them, 164 patients had a preoperative CTA scan eligible for analysis. One hundred twenty-six patients were male (76.8 %), with a mean age of 67 ± 10.8 years. Ninety-four patients (57.3%) were affected by atherosclerotic aneurysms, 48 post-dissecting aneurysms (29.3%) and 22 penetrating aortic ulcers (PAUs) (13.4%). Twenty patients (12.2%) were suitable for double-fenestrated C-PMEG, and 34 patients (20.7%) for single-fenestrated C-PMEG, totaling 32.9% of the entire cohort. The combination of supra-aortic trunks (SAT) bypass or the use of covered stent in IA or left common carotid artery (LCCA) as adjunctive maneuvers, would extend the C-PMEGs feasibility to 69 patients (42.1%). The use of an iliac graft conduit in 3 (1.8%) patients with inadequate ileo-femoral accesses would increase the C-PMEG suitability to 72 patients (43.9%). The main reason for exclusion was excessive ascending aortic diameter in 78 patients (47.6%). CONCLUSIONS: The use of C-PMEG was shown to be theoretically feasible in a percentage of patients ranging from 32.9 to 43.9% affected by aortic arch aneurysms, dissections, and PAU. The main reason for exclusion was the dimension of the ascending aorta. The C-PMEG technique is a viable option in aortic arch lesions endovascular treatment. An off-the-shelf device with similar characteristics could also be used in emergency, avoiding the limitations of physician modifications (such as time for back-table procedure, sterility, off-label use).Clinical ImpactThoracic endovascular aortic repair (TEVAR) has been extended to more proximal landing zones for the treatment of aortic arch aneurysm, dissections, penetrating aortic ulcers. Among total endovascular solutions, the "Canaud technique" for Physician-Modified Thoracic Endovascular Grafts (C-PMEGs) has gained acceptance with good early results. The anatomical feasibility in 164 consecutive patients was 69 patients (42.1%), with the combination of supra-aortic trunks (SAT) bypass or the use of covered stent in IA or left common carotid artery (LCCA) as adjunctive maneuvers, showing that the C-PMEG technique is a viable option in aortic arch lesions endovascular treatment.
引用
- Santoro A, Favia N, Valente FBA, et al. Anatomical Feasibility of the "Canaud Technique" for Physician-Modified Thoracic Endovascular Grafts for the Treatment of Aortic Arch Disease. J Endovasc Ther. 2024. PMID: 38850041. doi:10.1177/15266028241258148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。